CompletedNot Applicable

Proton Pump Inhibitors in Cirrhotic Patients

Egypt1,000 participantsStarted 2020-10-01

Plain-language summary

Proton pump inhibitors (PPIs) inappropriate use, in patients with cirrhosis, presents a significant clinical challenge. This study evaluates overprescription and misuse of PPIs in cirrhotic patients. The patterns of use of PPIs will be classified into two groups based on adherence to the proven indications: Group A: Inappropriate use of PPI, Group B: Appropriate use of PPI. We will estimate the prevalence of PPI misuse in cirrhotics and correlate it with different factors.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients receiving proton pump inhibitors at the time of enrollment. Exclusion Criteria: * Refusal to sign the informed consent form or failure to provide the required information

What they're measuring

Inappropriate use of PPIs

Timeframe: Six weeks after study completion

Predictors for inappropriate use of PPIs

Timeframe: Eight weeks after study completion

Trial details

NCT IDNCT06384443

SponsorNational Liver Institute, Egypt

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03-01

View on ClinicalTrials.gov More Proton Pump Inhibitor Adverse Reaction trials